News

Net profit of Global Health rose 42.00% to Rs 143.99 crore in the quarter ended March 2026 as against Rs 101.40 crore during the previous quarter ended March 2025. Sales rose 24.46% to Rs 1159.05 crore in the quarter ended March 2026 as against Rs 931.25 crore during the previous quarter ended March 2025.For the full year,net profit rose 15.58% to Rs 556.46 crore in the year ended March 2026 as against Rs 481.44 crore during the previous year ended March 2025. Sales rose 19.44% to Rs 4410.27 crore in the year ended March 2026 as against Rs 3692.35 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1159.05931.25 24 4410.273692.35 19 OPM %21.0324.13 -20.8423.76 - PBDT253.80232.59 9 938.58890.91 5 PBT187.28183.34 2 716.04697.16 3 NP143.99101.40 42 556.46481.44 16 Powered by Capital Market - Live News

Global Health announced that the Board of Directors of the Company at its meeting held on 14 May 2026, has recommended a Final Dividend of Rs.0.50 per share (i.e.25%), subject to the approval of the shareholders.

Global Health will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Global Health has allotted 61,500 equity shares under ESOP on 22 April 2026. Post allotment, the paid up equity share capital has increased to Rs. 53,77,03,764/- divided into 26,88,51,882 equity shares of Rs. 2/- each.

Global Health has received a communication from NSE Sustainability Ratings & Analytics informing that they have assigned an ESG rating of `69` for the Financial Year 2025 to the Company. Powered by Capital Market - Live News